Cytodyn Inc (CYDY)

[ohm20]

I do have a triple digit selling price entered GTC+extended for HGEN shares.

You may want to double check the science and comparative drugs and adjust your expectations.

I wonder if Nader speaks so automatically about a triple digit share price because he has subconsciously based that on a lower Outstanding Share count.

Not a chance it hits triple digits over the short term. Over the long term however it's a different story. When I only had 30 diseases on the disease list I did some rough figures and came up with a conservative $300 a share or a moderate $462 a share on approvals for those indications. I thought with a fast ramp up on revenue it might be done in 5-6 years.